Edgewise Therapeutics (EWTX) Earnings Date, Estimates & Call Transcripts $13.80 -0.52 (-3.60%) As of 03:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Edgewise Therapeutics Earnings Summary Edgewise Therapeutics announced Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.43, which beat analysts' consensus estimates of -$0.45 by $0.02. With a trailing EPS of -$1.55, Edgewise Therapeutics' earnings are expected to decrease next year, from ($1.45) to ($1.86) per share. Upcoming Q2 Earnings DateAug. 6Before Market OpensEstimatedConsensus EPS (May. 8) -$0.45 Actual EPS (May. 8) -$0.43 Beat By $0.02 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)EWTX Upcoming EarningsEdgewise Therapeutics' Q2 2025 earnings is scheduled for Wednesday, August 6, 2025, with a conference call scheduled on Thursday, August 7, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Edgewise Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Edgewise Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataEWTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Edgewise Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.44-$0.40-$0.42Q2 20252-$0.49-$0.41-$0.45Q3 20252-$0.51-$0.45-$0.48Q4 20252-$0.55-$0.46-$0.51 FY 2025 8 -$1.99 -$1.72 -$1.86 Q1 20261-$0.52-$0.52-$0.52Q2 20261-$0.55-$0.55-$0.55Q3 20261-$0.58-$0.58-$0.58Q4 20261-$0.60-$0.60-$0.60 Edgewise Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)--------5/8/2025Q1 2025-$0.45-$0.43+$0.02-$0.43--3/3/2025Q4 2024-$0.39-$0.42 -$0.03-$0.42--11/7/2024Q3 2024-$0.37-$0.36+$0.01-$0.36--8/8/2024--$0.36-$0.34+$0.02-$0.34--5/9/2024Q1 2024-$0.39-$0.33+$0.06-$0.33--2/22/2024Q4 2023-$0.44-$0.47 -$0.03-$0.47--11/9/2023Q3 2023-$0.40-$0.41 -$0.01-$0.41--8/10/2023Q2 2023-$0.41-$0.34+$0.07-$0.34-- Edgewise Therapeutics Earnings - Frequently Asked Questions When is Edgewise Therapeutics' earnings date? Edgewise Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on EWTX's earnings history. Did Edgewise Therapeutics beat their earnings estimates last quarter? In the previous quarter, Edgewise Therapeutics (NASDAQ:EWTX) reported ($0.43) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.02. Learn more on analysts' earnings estimate vs. EWTX's actual earnings. How much profit does Edgewise Therapeutics generate each year? Edgewise Therapeutics (NASDAQ:EWTX) has a recorded net income of -$133.81 million. EWTX has generated -$1.55 earnings per share over the last four quarters. What is Edgewise Therapeutics' EPS forecast for next year? Edgewise Therapeutics' earnings are expected to decrease from ($1.45) per share to ($1.86) per share in the next year. More Earnings Resources from MarketBeat Related Companies TG Therapeutics Earnings Results Nuvalent Earnings Results CRISPR Therapeutics Earnings Results Rhythm Pharmaceuticals Earnings Results Lantheus Earnings Results Axsome Therapeutics Earnings Results Vaxcyte Earnings Results Merus Earnings Results Cytokinetics Earnings Results Avidity Biosciences Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Why Robinhood Just Added Upside Potential After a Q2 Earnings DipMicrosoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead? This page (NASDAQ:EWTX) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThe Altcoin That Could be Poised to Benefit Most from Trump’s ReturnWith Trump back in office, the crypto tide is turning fast. Regulation is easing. Momentum is building. And ac...Weiss Ratings | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.